Discussion of new data from the ADAGIO trial for the treatment of Parkinson's disease, and a Canadian cohort study assessing risk factors for multiple sclerosis in children.

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv